Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (381-390 of 504) with videos related to

Pageof 51
Sort By:
Critical Care Medicine|January 25, 2019
Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress SyndromeThomas Kiss, Thomas Bluth, Anja Braune, et al.
Blood Advances|January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosisPrajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
American Journal of Hematology|July 31, 2016
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyNicholas J Short, Christopher B Benton, Hsiang-Chun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemiaFarhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Blood Cancer Journal|October 21, 2018
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensGeorge Z Rassidakis, Nikolas Herold, Ida Hed Myrberg, et al.
Blood|March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemiaRamiro Garzon, Michael Savona, Rachid Baz, et al.
Cancer|March 9, 2023
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulationDaniel Nguyen, Hagop M Kantarjian, Nicholas J Short, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Pageof 51

Showing results (381-390 of 504) with videos related to

Sort By:
Pageof 51
Critical Care Medicine|January 25, 2019
Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress SyndromeThomas Kiss, Thomas Bluth, Anja Braune, et al.
Blood Advances|January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosisPrajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
American Journal of Hematology|July 31, 2016
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyNicholas J Short, Christopher B Benton, Hsiang-Chun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemiaFarhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Cancer Discovery|April 24, 2023
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid LeukemiaChristina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Blood Cancer Journal|October 21, 2018
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensGeorge Z Rassidakis, Nikolas Herold, Ida Hed Myrberg, et al.
Blood|March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemiaRamiro Garzon, Michael Savona, Rachid Baz, et al.
Cancer|March 9, 2023
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulationDaniel Nguyen, Hagop M Kantarjian, Nicholas J Short, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Pageof 51